Affiliation:
1. Columbia University School of Nursing New York New York
Subject
Maternity and Midwifery,Obstetrics and Gynaecology
Reference26 articles.
1. Current contraceptive use and variation by selected characteristics among women aged 15‐44: United States, 2011‐2013;Daniels K;Natl Health Stat Report,2015
2. US Food & Drug Administration.Depo‐SubQ Provera 104 (Medroxyprogesterone Acetate) injectable suspension new drug application No.: 021583. Updated May 9 2007. Accessed September 9 2007.https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021583s000TOC.cfm
3. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate
4. Early Impacts of the COVID-19 Pandemic: Findings from the 2020 Guttmacher Survey of Reproductive Health Experiences
5. Long-acting injectable contraception with depot medroxyprogesterone acetate
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献